1. Home
  2. OGI vs MDWD Comparison

OGI vs MDWD Comparison

Compare OGI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGI
  • MDWD
  • Stock Information
  • Founded
  • OGI 2013
  • MDWD 2000
  • Country
  • OGI Canada
  • MDWD Israel
  • Employees
  • OGI N/A
  • MDWD N/A
  • Industry
  • OGI Biotechnology: Pharmaceutical Preparations
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • OGI Health Care
  • MDWD Health Care
  • Exchange
  • OGI Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • OGI 176.1M
  • MDWD 179.1M
  • IPO Year
  • OGI N/A
  • MDWD 2014
  • Fundamental
  • Price
  • OGI $1.84
  • MDWD $17.61
  • Analyst Decision
  • OGI
  • MDWD Strong Buy
  • Analyst Count
  • OGI 0
  • MDWD 1
  • Target Price
  • OGI N/A
  • MDWD $28.00
  • AVG Volume (30 Days)
  • OGI 537.8K
  • MDWD 60.7K
  • Earning Date
  • OGI 08-13-2024
  • MDWD 08-14-2024
  • Dividend Yield
  • OGI N/A
  • MDWD N/A
  • EPS Growth
  • OGI N/A
  • MDWD N/A
  • EPS
  • OGI N/A
  • MDWD N/A
  • Revenue
  • OGI $110,297,722.00
  • MDWD $20,141,000.00
  • Revenue This Year
  • OGI $8.76
  • MDWD $30.16
  • Revenue Next Year
  • OGI $14.04
  • MDWD $18.44
  • P/E Ratio
  • OGI N/A
  • MDWD N/A
  • Revenue Growth
  • OGI 2.33
  • MDWD N/A
  • 52 Week Low
  • OGI $0.97
  • MDWD $7.45
  • 52 Week High
  • OGI $2.91
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • OGI 52.42
  • MDWD 48.27
  • Support Level
  • OGI $1.76
  • MDWD $16.25
  • Resistance Level
  • OGI $1.89
  • MDWD $17.48
  • Average True Range (ATR)
  • OGI 0.09
  • MDWD 1.04
  • MACD
  • OGI -0.01
  • MDWD -0.12
  • Stochastic Oscillator
  • OGI 36.36
  • MDWD 31.63

About OGI Organigram Holdings Inc.

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: